Expertise in
45
conditions

Dr. Scott Soltys

Radiation Oncology
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
45
conditions
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 

Overview

Scott Soltys is a Radiation Oncologist practicing medicine in Palo Alto, California.

Dr. Soltys is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Brain Tumor, Astrocytoma, Meningioma, and Rhizotomy.

He is actively involved in clinical research, co-authoring 185 peer reviewed articles and participating in 7 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in CA

Hospital Affiliations

Stanford Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Stanford University
875 Blake Wilbur Dr, Palo Alto, CA 94304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: January 14, 2026
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
A Phase 1 Study of Tumor Treating Fields With 5 Day Hypofractionated Stereotactic Radiosurgery and Concurrent and Maintenance Temozolomide in Newly Diagnosed Glioblastoma
A Phase 1 Study of Tumor Treating Fields With 5 Day Hypofractionated Stereotactic Radiosurgery and Concurrent and Maintenance Temozolomide in Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: December 26, 2025
Intervention Type: Device, Drug, Radiation
Study Drugs: Gadolinium, Temozolomide
Study Phase: Phase 1
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
A Pilot Study of Perfusion CT for Lung Tumors Treated With Stereotactic Ablative Radiation Therapy (SABR)
A Pilot Study of Perfusion CT for Lung Tumors Treated With Stereotactic Ablative Radiation Therapy (SABR)
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug, Radiation, Device
Study Drug: Isovue-200
Study Phase: Phase 1
A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Enrollment Status: Completed
Publish Date: October 28, 2021
Investigation of Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Investigation of Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Enrollment Status: Completed
Publish Date: October 28, 2021
A Phase 1-2 Trial of Temozolomide and Hypofractionated Radiotherapy in Treatment of Supratentorial Glioblastoma Multiforme
A Phase 1-2 Trial of Temozolomide and Hypofractionated Radiotherapy in Treatment of Supratentorial Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: August 06, 2021
Intervention Type: Drug, Procedure
Study Drug: Temozolomide
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

185 Total Publications

Transformer-encoded nnU-Net with local region perceptron and contrastive learning (TLC-nnUNet) for multiple brain metastasis detection and delineation.
Transformer-encoded nnU-Net with local region perceptron and contrastive learning (TLC-nnUNet) for multiple brain metastasis detection and delineation.
Journal: Physics in medicine and biology
Published: November 12, 2025
Similar Doctors
Expertise in
15
conditions
Dr. Richard Hoppe
Radiation Oncology
Expertise in
15
conditions
Dr. Richard Hoppe
Radiation Oncology

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (1.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances

Richard Hoppe is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Hoppe is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Mycosis Fungoides, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Cutaneous T-Cell Lymphoma (CTCL).

Expertise in
9
conditions
Dr. Maximilian Diehn
Radiation Oncology
Expertise in
9
conditions
Dr. Maximilian Diehn
Radiation Oncology

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (0.2 miles away)
650-723-6171
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maximilian Diehn is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Diehn is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

Expertise in
46
conditions
Dr. Erqi Pollom
Radiation Oncology
Expertise in
46
conditions
Dr. Erqi Pollom
Radiation Oncology

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (0.2 miles away)
650-498-6339
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Erqi Pollom is a Radiation Oncologist practicing medicine in Palo Alto, California. Dr. Pollom is highly rated in 46 conditions, according to our data. Her clinical expertise encompasses Metastatic Brain Tumor, Brain Tumor, Glioblastoma, Anal Cancer, and Pancreatectomy.

Frequently Asked Questions about Dr. Scott Soltys

How do I make an appointment with Dr. Scott Soltys?

You can book an appointment with Dr. Scott Soltys by calling their office at 650-724-1569. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Scott Soltys a top-rated expert for Metastatic Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott Soltys is classified as an Elite expert for Metastatic Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Scott Soltys specialize in?

While Dr. Scott Soltys is a Radiation Oncology, they have specific expertise in Metastatic Brain Tumor, Brain Tumor, and Astrocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Scott Soltys participate in research or clinical trials?

Yes. Dr. Scott Soltys has published 185 articles and abstracts on conditions like Metastatic Brain Tumor. You can view a list of Dr. Scott Soltys's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Scott Soltys accept my insurance?

Dr. Scott Soltys accepts most major insurance plans, including Aetna and Blue Shield of California. We recommend calling the office directly at 650-724-1569 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Soltys's expertise for a condition
ConditionClose
View All 22 Distinguished Conditions
View All 19 Advanced Conditions
View All 52 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile